Count Me In: Partnering with Patients to Define the Landscape of Rare, Aggressive Sarcomas
Attend this seminar to discover how the nonprofit research initiative “Count Me In” is partnering researchers with patients to understand rare, aggressive cancers. Harvard Medical School’s Dr. Katherine Janeway will elaborate on the initiative’s particular work with osteosarcoma and leiomyosarcoma.
The Cancer MoonshotSM Seminar Series showcases the research progress of different Cancer Moonshot initiatives.
The Cancer Moonshot Blue Ribbon Panel of scientific experts created a report outlining 10 recommendations. These recommendations are meant to accelerate progress in cancer prevention, diagnosis, and treatment.
Dr. Janeway is an associate professor of pediatrics at Harvard Medical School and a senior physician of pediatric oncology at Dana-Farber Cancer Institute.
Upcoming Events
- Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncologyJuly 30, 2024CCDI Federated Data: Enhancing Data DiscoverabilityAugust 13, 2024Leveraging High-Performance Computing Resources and Using QIIME 2 to Advance Your Microbiome ProjectsAugust 27, 2024 - August 29, 2024NCI Office of Data Sharing’s Annual Data Sharing Symposium: Driving Cancer Advances Through Impactful ResearchOctober 16, 2024The Cancer Research Data Commons 2024 Fall Symposium: Ten Years of Empowering Cancer ResearchersOctober 16, 2024 - October 17, 2024